Although this class of drugs, called glucagon-like peptide-1 or GLP-1, have been around for more than 17 years, with the first one, Byetta, approved in 2005, it is only recently that the class has made a big name for itself with the introduction of the popular once-weekly diabetic drug, Ozempic , and the equally popular obesity drug, Wegovy (the same drug as Ozempic but with a different dose)
References: He, B., Wang, F., & Qu, L
Private weight loss injections are safe as long as you use a regulated and reputable provider
Chong SJF, Lai JXH, Eu JQ, Bellot GL, Pervaiz S
The hardest task facing researchers is finding a reputable peptide vendor that makes good on its promises
Carnitine in perinatal metabolism of lipids